This Biocluster aims to establish Marseille as a world-class center for immunotherapy. Involving public and private players, MIB brings together experts in immunology (research, industry, healthcare, training, start-ups), with strong support from local authorities such as the Aix-Marseille-Provence Metropolis, the Bouches-du-Rhône Department and the Provence-Alpes-Côte-d’Azur Region.
About
Marseille Immunology Biocluster (MIB) is a winning project in France’s national “Bioclusters” call for projects, with a government investment of €96 million.
€96 million
State investment
It brings together major players in research, healthcare, innovation and local authorities, and aims to accelerate the development of immunotherapy antibodies against serious diseases such as inflammatory and autoimmune diseases, cancers and infections.
Marseille Immunology Biocluster (MIB) is a winning project in France’s national “Bioclusters” call for projects, with a government investment of €96 million.
Receive quarterly news from the Marseille Immunology Biocluster.
Your e-mail address will only be used to send this newsletter, and you can unsubscribe at any time.
Find out more about how we manage your personal data
